CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma von Chen, Xiaocheng, Wong, Oi Kwan, Reiman, Lauren, Sherbenou, Daniel W, Post, Leonard

Volltext

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma von Davis, Lorraine N, Sherbenou, Daniel W

Volltext

Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia von Minhajuddin, Mohd, Winters, Amanda, Ye, Haobin, Pei, Shanshan, Stevens, Brett, Gillen, Austin, Engel, Krysta, Gipson, Stephanie, Ransom, Monica, Amaya, Maria, Inguva, Anagha, Gasparetto, Maura, Althoff, Mark J, Miller, Regan, Shelton, Ian, Tolison, Hunter, Krug, Anna, Culp-Hill, Rachel, D'Alessandro, Angelo, Sherbenou, Daniel W, Pollyea, Daniel A, Smith, Clayton, Jordan, Craig T

Volltext

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells von Sherbenou, Daniel W, Aftab, Blake T, Su, Yang, Behrens, Christopher R, Wiita, Arun, Logan, Aaron C, Acosta-Alvear, Diego, Hann, Byron C, Walter, Peter, Shuman, Marc A, Wu, Xiaobo, Atkinson, John P, Wolf, Jeffrey L, Martin, Thomas G, Liu, Bin

Volltext

Disruption of IRE1α through its kinase domain attenuates multiple myeloma von Harnoss, Jonathan M., Le Thomas, Adrien, Shemorry, Anna, Marsters, Scot A., Lawrence, David A., Lu, Min, Chen, Yung-Chia Ariel, Qing, Jing, Totpal, Klara, Kan, David, Segal, Ehud, Merchant, Mark, Reichelt, Mike, Wallweber, Heidi Ackerly, Wang, Weiru, Clark, Kevin, Kaufman, Susan, Beresini, Maureen H., Laing, Steven T., Sandoval, Wendy, Lorenzo, Maria, Wu, Jiansheng, Ly, Justin, De Bruyn, Tom, Heidersbach, Amy, Haley, Benjamin, Gogineni, Alvin, Weimer, Robby M., Lee, Dong, Braun, Marie-Gabrielle, Rudolph, Joachim, VanWyngarden, Michael J., Sherbenou, Daniel W., Gomez-Bougie, Patricia, Amiot, Martine, Acosta-Alvear, Diego, Walter, Peter, Ashkenazi, Avi

Volltext

Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma von Sherbenou, Daniel W, Su, Yang, Behrens, Christopher R, Aftab, Blake T, Perez de Acha, Olivia, Murnane, Megan, Bearrows, Shelby C, Hann, Byron C, Wolf, Jeffery L, Martin, Thomas G, Liu, Bin

Volltext

Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future von Sherbenou, Daniel W., Mark, Tomer M., Forsberg, Peter

Volltext

Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm von Keller, Alana L, Sherbenou, Daniel W, Forsberg, Peter A, Mark, Tomer M

Volltext

Applying the discovery of the Philadelphia chromosome von Sherbenou, Daniel W, Druker, Brian J

Volltext

Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy von Walker, Zachary J, Idler, Beau M, Davis, Lorraine N, Stevens, Brett M, VanWyngarden, Michael J, Ohlstrom, Denis, Bearrows, Shelby C, Hammes, Andrew, Smith, Clayton A, Jordan, Craig T, Mark, Tomer M, Forsberg, Peter A, Sherbenou, Daniel W

Volltext

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer von Su, Yang, Liu, Yue, Behrens, Christopher R, Bidlingmaier, Scott, Lee, Nam-Kyung, Aggarwal, Rahul, Sherbenou, Daniel W, Burlingame, Alma L, Hann, Byron C, Simko, Jeffry P, Premasekharan, Gayatri, Paris, Pamela L, Shuman, Marc A, Seo, Youngho, Small, Eric J, Liu, Bin

Volltext

CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts von VanWyngarden, Michael J, Walker, Zachary J, Su, Yang, Perez de Acha, Olivia, Stevens, Brett M, Forsberg, Peter A, Mark, Tomer M, Matsui, William, Liu, Bin, Sherbenou, Daniel W

Volltext

Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis von Lakritz, Stephanie, Forsberg, Peter A., Sherbenou, Daniel W., Mark, Tomer M.

Volltext

Cell-type specific potent Wnt signaling blockade by bispecific antibody von Lee, Nam-Kyung, Zhang, Yafeng, Su, Yang, Bidlingmaier, Scott, Sherbenou, Daniel W., Ha, Kevin D., Liu, Bin

Volltext

Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant von Sharma, Prashant, Purev, Enkhtsetseg, Haverkos, Bradley, Pollyea, Daniel A., Cherry, Evan, Kamdar, Manali, Mark, Tomer, Forsberg, Peter, Sherbenou, Daniel, Hammes, Andrew, Rabinovitch, Rachel, Smith, Clayton A., Gutman, Jonathan A.

Volltext

The development of potential antibody-based therapies for myeloma von Sherbenou, Daniel W, Behrens, Christopher R, Su, Yang, Wolf, Jeffrey L, Martin, Thomas G, Liu, Bin

Volltext

BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib von Sherbenou, Daniel W., Hantschel, Oliver, Kaupe, Ines, Willis, Stephanie, Bumm, Thomas, Turaga, Lalita P., Lange, Thoralf, Dao, Kim-Hien, Press, Richard D., Druker, Brian J., Superti-Furga, Giulio, Deininger, Michael W.

Volltext

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies von Perez de Acha, Olivia, Reiman, Lauren, Jayabalan, David S., Walker, Zachary J., Bosma, Grace, Keller, Alana L., Parzych, Sarah E., Abbott, Diana, Idler, Beau M., Ribadeneyra, Drew, Niesvizky, Ruben, Forsberg, Peter A., Mark, Tomer M., Sherbenou, Daniel W.

Volltext

Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression von Ohlstrom, Denis, Walker, Zachary J, Pandey, Abhishek, Davis, Lorraine N, Engel, Krysta L, Pan, Zenggang, Forsberg, Peter A, Mark, Tomer M, Gillen, Austin E, Sherbenou, Daniel W

Volltext

309 MYC Inhibition Overcomes IMiD Resistance in Heterogeneous Multiple Myeloma Populations von Davis, Lorraine, Walker, Zachary J., Ohlstrom, Denis, Stevens, Brett M., Forsberg, Peter A., Mark, Tomer M., Jordan, Craig T., Sherbenou, Daniel W.

Volltext